Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AAAS ENSG00000094914 Achalasia, adrenocortical insufficiency, alacrimia 12 53307456-53324864 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040086 Approved Approved Nuclear membrane
Centrosome
Cytosol Expressed in all parathyroid gland: 44.9 ADIPOR1 ACDCR1, PAQR1 ENSG00000159346 Adiponectin receptor 1 1 202940823-202958572 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all placenta: 135.5 AHCTF1 ELYS ENSG00000153207 AT hook containing transcription factor 1 1 246839098-246931978 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031658 Uncertain Supported Nuclear membrane Expressed in all testis: 61.2 ANO1 DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A ENSG00000131620 Anoctamin 1, calcium activated chloride channel 11 70078302-70189528 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032148 Supported Tissue enhanced 0 epididymis: 217.7;seminal vesicle: 295.7 skin: 116.0 ANO2 C12orf3, TMEM16B ENSG00000047617 Anoctamin 2, calcium activated chloride channel 12 5531869-5946232 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA036276 Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 testis: 17.7 placenta: 5.9 ANO3 C11orf25, DYT23, GENX-3947, TMEM16C ENSG00000134343 Anoctamin 3 11 26309599-26663288 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA041629 Uncertain Tissue enriched 6 epididymis: 61.3 cerebral cortex: 10.6 ANO5 GDD1, LGMD2L, TMEM16E ENSG00000171714 Anoctamin 5 11 22193176-22283357 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058857 Uncertain Tissue enhanced 0 parathyroid gland: 55.2 skeletal muscle: 23.6 ANO6 DKFZp313M0720, TMEM16F ENSG00000177119 Anoctamin 6 12 45215987-45440404 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038958 Approved Approved Plasma membrane
Cytosol Expressed in all adipose tissue: 90.8 ANO9 PIG5, TMEM16J, TP53I5 ENSG00000185101 Anoctamin 9 11 417933-442011 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039948, HPA040112 Approved Uncertain Golgi apparatus Tissue enhanced 0 duodenum: 32.4;small intestine: 31.6 skin: 21.6 ANXA1 ANX1, LPC1 ENSG00000135046 Annexin A1 9 73151757-73170393 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011271, HPA011272, CAB013023, CAB035987, CAB058693 Supported Validated Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 6 esophagus: 7577.8 tonsil: 1266.5 ANXA2 ANX2, ANX2L4, CAL1H, LIP2, LPC2D ENSG00000182718 Annexin A2 15 60347134-60402883 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004311 Approved Expressed in all esophagus: 1494.3 ANXA6 ANX6 ENSG00000197043 Annexin A6 5 151100712-151157882 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002462, CAB005077, HPA009650 Supported Approved Nuclear speckles Expressed in all smooth muscle: 426.1 APCS MGC88159, PTX2, SAP ENSG00000132703 Amyloid P component, serum 1 159587825-159588865 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007817, HPA053294 Supported Tissue enriched 25 liver: 1844.2 gallbladder: 73.9 APP AD1 ENSG00000142192 Amyloid beta (A4) precursor protein 21 25880550-26171128 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000157, HPA001462 Supported Approved Golgi apparatus
Vesicles Expressed in all cerebral cortex: 1206.8 AQP1 CHIP28, CO ENSG00000240583 Aquaporin 1 (Colton blood group) 7 30911855-30925516 Blood group antigen proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001707, HPA019206 Supported Supported Plasma membrane Expressed in all kidney: 801.2 AQP10 ENSG00000143595 Aquaporin 10 1 154321090-154325325 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065947 Supported Group enriched 8 duodenum: 70.3;small intestine: 50.1 fallopian tube: 7.1 AQP11 ENSG00000178301 Aquaporin 11 11 77589391-77610355 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042879 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 duodenum: 24.8;small intestine: 23.6 adrenal gland: 10.1 AQP12A AQP12 ENSG00000184945 Aquaporin 12A 2 240691845-240698483 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA042216 Supported Tissue enriched 67 pancreas: 27.7 small intestine: 0.4 AQP2 ENSG00000167580 Aquaporin 2 (collecting duct) 12 49950741-49958881 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046834 Supported Group enriched 93 kidney: 432.9;seminal vesicle: 299.3 prostate: 3.9 AQP4 MIWC ENSG00000171885 Aquaporin 4 18 26852038-26865818 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005079, HPA014784, CAB058689 Supported Supported Supported Plasma membrane
Cell Junctions Group enriched 17 cerebral cortex: 631.8;lung: 172.2 thyroid gland: 24.3 AQP5 ENSG00000161798 Aquaporin 5 12 49961870-49965681 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065008 Supported Approved Plasma membrane Group enriched 8 salivary gland: 257.1;stomach: 54.0;testis: 176.5 breast: 21.0 AQP6 AQP2L ENSG00000086159 Aquaporin 6, kidney specific 12 49967194-49977139 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA015278 Supported Tissue enriched 9 kidney: 20.8 cerebral cortex: 2.3 AQP7 AQP7L, AQP9, AQPap ENSG00000165269 Aquaporin 7 9 33383179-33402682 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adipose tissue: 315.4 parathyroid gland: 65.5 AQP8 ENSG00000103375 Aquaporin 8 16 25215731-25228940 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046259 Approved Group enriched 132 colon: 325.1;pancreas: 269.4;rectum: 169.2 smooth muscle: 1.9 BAK1 BAK, BCL2L7, CDN1 ENSG00000030110 BCL2-antagonist/killer 1 6 33572547-33580293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005029 Supported Expressed in all duodenum: 49.2 BASP1 CAP-23, CAP23, NAP-22, NAP22 ENSG00000176788 Brain abundant, membrane attached signal protein 1 5 17065598-17276843 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045218, HPA050333 Supported Validated Plasma membrane Tissue enhanced 0 cerebral cortex: 420.3;epididymis: 364.8 prostate: 133.3 BAX BCL2L4 ENSG00000087088 BCL2-associated X protein 19 48954815-48961798 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004206, HPA027878 Approved Expressed in all appendix: 83.2 BCL2L1 Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52 ENSG00000171552 BCL2-like 1 20 31664452-31723989 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035734, CAB072801 Approved Approved Mitochondria Expressed in all gallbladder: 100.9 BCL2L2 BCL-W, KIAA0271, PPP1R51 ENSG00000129473 BCL2-like 2 14 23298790-23311759 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB040539 Approved Expressed in all cerebral cortex: 89.1 BCL2L2-PABPN1 ENSG00000258643 BCL2L2-PABPN1 readthrough 14 23306835-23325369 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA000637 Approved Approved Mixed seminal vesicle: 28.8 BEST1 BEST, BMD, RP50, VMD2 ENSG00000167995 Bestrophin 1 11 61949821-61965515 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA057464 Supported Mixed cerebral cortex: 17.0 BEST2 FLJ20132, VMD2L1 ENSG00000039987 Bestrophin 2 19 12751702-12758458 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046229 Approved Tissue enhanced 0 colon: 15.8;rectum: 15.4 tonsil: 4.9 BNIP3 Nip3 ENSG00000176171 BCL2/adenovirus E1B 19kDa interacting protein 3 10 131966455-131982013 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003015, CAB011676 Supported Uncertain Cytosol Expressed in all cerebral cortex: 84.4 BNIP3L BNIP3a, Nix ENSG00000104765 BCL2/adenovirus E1B 19kDa interacting protein 3-like 8 26382898-26505636 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015652, CAB025371 Supported Approved Nuclear speckles
Mitochondria Expressed in all placenta: 150.7 BPI BPIFD1 ENSG00000101425 Bactericidal/permeability-increasing protein 20 38260149-38337505 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061284 Supported Tissue enriched 36 bone marrow: 963.1 testis: 27.0 BRI3BP BNAS1, HCCR-2, KG19 ENSG00000184992 BRI3 binding protein 12 124993700-125031231 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014957 Approved Approved Nucleoplasm
Mitochondria Mixed duodenum: 21.1 C6 ENSG00000039537 Complement component 6 5 41142234-41261438 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043823, CAB069427 Supported Group enriched 7 fallopian tube: 72.6;liver: 357.7 heart muscle: 30.6 C8A ENSG00000157131 Complement component 8, alpha polypeptide 1 56854806-56918221 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 63 liver: 328.4 gallbladder: 5.2 CACFD1 C9orf7, D9S2135, flower ENSG00000160325 Calcium channel flower domain containing 1 9 133459965-133470848 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015280 Approved Nucleoplasm Expressed in all thyroid gland: 16.6 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supported Approved Nucleoplasm
Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 18.1 stomach: 6.4 CACNA1C CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS ENSG00000151067 Calcium channel, voltage-dependent, L type, alpha 1C subunit 12 1970786-2697950 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039796 Supported Tissue enhanced 0 smooth muscle: 30.9 endometrium: 26.2 CACNA1F AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2 ENSG00000102001 Calcium channel, voltage-dependent, L type, alpha 1F subunit X 49205063-49233371 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed lymph node: 1.6 CACNA1H Cav3.2 ENSG00000196557 Calcium channel, voltage-dependent, T type, alpha 1H subunit 16 1153241-1221771 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA039125 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 ovary: 50.6 seminal vesicle: 46.9 CALCA CALC1 ENSG00000110680 Calcitonin-related polypeptide alpha 11 14966668-14972354 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 77 parathyroid gland: 832.9;thyroid gland: 181.9 kidney: 6.6 CALHM1 FAM26C ENSG00000185933 Calcium homeostasis modulator 1 10 103453387-103458888 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018317 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 kidney: 0.6 CALHM2 FAM26B ENSG00000138172 Calcium homeostasis modulator 2 10 103446786-103452402 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014706 Approved Approved Nucleoplasm
Mitochondria
Cytosol Mixed ovary: 44.9 CALHM3 bA225H22.7, FAM26A ENSG00000183128 Calcium homeostasis modulator 3 10 103472804-103479240 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018205 Uncertain Approved Nucleoplasm Not detected testis: 0.4 CATSPER3 CACRC ENSG00000152705 Cation channel, sperm associated 3 5 134967906-135011707 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 26 testis: 38.3 fallopian tube: 1.4 CATSPER4 ENSG00000188782 Cation channel, sperm associated 4 1 26190561-26202968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA045257 Supported Tissue enriched 63 testis: 9.7 skin: 0.1 CATSPERB C14orf161, FLJ14298 ENSG00000133962 Catsper channel auxiliary subunit beta 14 91580696-91780707 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035134 Uncertain Uncertain Vesicles Mixed skin: 2.7 CATSPERD MGC39581, TMEM146 ENSG00000174898 Catsper channel auxiliary subunit delta 19 5720677-5778734 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024056 Supported Tissue enriched 160 testis: 15.9 epididymis: 0.0 CATSPERG C19orf15, DKFZp434A1022, FLJ46353 ENSG00000099338 Catsper channel auxiliary subunit gamma 19 38335775-38370943 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052777 Approved Nucleus
Nucleoli
Cytosol Tissue enriched 41 testis: 48.5 skin: 1.1 CAV3 LGMD1C, LQT9, VIP-21, VIP21 ENSG00000182533 Caveolin 3 3 8733800-8841808 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017518, CAB018557, HPA054488 Supported Supported Vesicles
Plasma membrane Group enriched 6 heart muscle: 13.0;skeletal muscle: 63.3 esophagus: 6.0 CCDC109B FLJ20647 ENSG00000005059 Coiled-coil domain containing 109B 4 109560205-109688726 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048776 Approved Approved Nucleoplasm
Cytosol Mixed lymph node: 36.7 CCNB1 CCNB ENSG00000134057 Cyclin B1 5 69167010-69178245 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000115, CAB003804, HPA030741, HPA061448 Supported Validated Cytosol Mixed lymph node: 66.3 CCNB2 HsT17299 ENSG00000157456 Cyclin B2 15 59105078-59125045 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008873, CAB009575 Supported Validated Golgi apparatus
Cytosol Tissue enhanced 0 testis: 122.0 bone marrow: 44.8 CDK1 CDC2, CDC28A ENSG00000170312 Cyclin-dependent kinase 1 10 60778331-60794852 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003387, CAB003799 Uncertain Validated Nucleus
Cytosol Mixed lymph node: 48.1 CHRNA1 CHRNA ENSG00000138435 Cholinergic receptor, nicotinic, alpha 1 (muscle) 2 174747592-174764472 Disease related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA071554 Supported Plasma membrane Tissue enhanced 0 skeletal muscle: 7.2 prostate: 2.6 CHRNA4 BFNC, EBN, EBN1 ENSG00000101204 Cholinergic receptor, nicotinic, alpha 4 (neuronal) 20 63343223-63378401 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB034064 Uncertain Tissue enhanced 0 cerebral cortex: 6.8;parathyroid gland: 16.9 liver: 3.7 CHRNA7 ENSG00000175344 Cholinergic receptor, nicotinic, alpha 7 (neuronal) 15 32030488-32172521 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA029422, CAB033624 Supported Tissue enhanced 0 adrenal gland: 6.0;small intestine: 6.0 stomach: 3.6 CHRNB1 CHRNB ENSG00000170175 Cholinergic receptor, nicotinic, beta 1 (muscle) 17 7445061-7457707 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA005822, CAB011200 Approved Expressed in all skeletal muscle: 43.9 CHRNB2 ENSG00000160716 Cholinergic receptor, nicotinic, beta 2 (neuronal) 1 154567781-154580026 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 14 cerebral cortex: 22.0 adrenal gland: 1.5 CHRND ACHRD ENSG00000135902 Cholinergic receptor, nicotinic, delta (muscle) 2 232525993-232536667 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 14 skeletal muscle: 9.6 prostate: 0.6 CHRNE ACHRE ENSG00000108556 Cholinergic receptor, nicotinic, epsilon (muscle) 17 4897774-4903074 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 27 heart muscle: 34.4 epididymis: 1.2 CHRNG ACHRG ENSG00000196811 Cholinergic receptor, nicotinic, gamma (muscle) 2 232539727-232546403 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 19 skeletal muscle: 8.2 prostate: 0.4 CLCA1 CaCC, CLCRG1 ENSG00000016490 Chloride channel accessory 1 1 86468368-86500289 Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052787, HPA059301 Supported Group enriched 8 colon: 713.1;duodenum: 906.3;rectum: 1141.9;small intestine: 1551.5 appendix: 139.7 CLCC1 MCLC ENSG00000121940 Chloride channel CLIC-like 1 1 108929508-108963457 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009087, HPA013210 Supported Validated Endoplasmic reticulum Expressed in all parathyroid gland: 38.0 CLDN1 ILVASC, SEMP1 ENSG00000163347 Claudin 1 3 190305701-190322475 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002602, HPA048319 Supported Tissue enhanced 0 skin: 306.9;smooth muscle: 183.5 liver: 158.3 CLDN15 ENSG00000106404 Claudin 15 7 101232092-101238820 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 16 duodenum: 248.2;small intestine: 187.4 spleen: 13.5 CLDN16 HOMG3, PCLN1 ENSG00000113946 Claudin 16 3 190322541-190412143 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA056020 Supported Tissue enriched 6 kidney: 51.3 thyroid gland: 8.7 CLDN17 MGC126552, MGC126554 ENSG00000156282 Claudin 17 21 30165564-30166756 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA045903 Supported Tissue enriched 5 esophagus: 6.6 tonsil: 1.3 CLDN19 ENSG00000164007 Claudin 19 1 42733093-42740254 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 12 kidney: 19.6;placenta: 14.4 breast: 1.4 CLDN22 CLDN21 ENSG00000177300 Claudin 22 4 183318194-183320774 Predicted membrane proteins, Transporters Evidence at transcript level No evidence Evidence at transcript level Not detected epididymis: 0.1 CLDN23 CLDNL ENSG00000253958 Claudin 23 8 8701938-8704106 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA070578 Uncertain Nucleus
Plasma membrane Tissue enhanced 0 colon: 24.1;stomach: 24.9 small intestine: 16.9 CLDN3 C7orf1, CPE-R2, CPETR2, HRVP1, RVP1 ENSG00000165215 Claudin 3 7 73768997-73770270 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002702, HPA014361 Supported Supported Cell Junctions Tissue enhanced 0 colon: 89.6;small intestine: 121.9 duodenum: 56.5 CLDN4 CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8 ENSG00000189143 Claudin 4 7 73799542-73832693 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002610 Supported Supported Plasma membrane Mixed colon: 212.3 CLDN5 AWAL, BEC1, CPETRL1, TMVCF ENSG00000184113 Claudin 5 22 19523024-19527545 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB002607 Approved Tissue enhanced 0 adipose tissue: 128.2 lung: 53.8 CLDN7 CEPTRL2, CPETRL2, Hs.84359 ENSG00000181885 Claudin 7 17 7259903-7263983 Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013063, HPA014703, HPA073662 Supported Approved Vesicles
Cell Junctions Mixed small intestine: 357.1 CLDN8 ENSG00000156284 Claudin 8 21 30214006-30216073 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA060605 Approved Tissue enhanced 0 breast: 84.5;kidney: 75.5;rectum: 56.8 thyroid gland: 37.2 CLIC1 NCC27, p64CLCP ENSG00000213719 Chloride intracellular channel 1 6 31730581-31739763 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020825, CAB040557 Supported Supported Cytosol Expressed in all rectum: 71.3 CLIC2 XAP121 ENSG00000155962 Chloride intracellular channel 2 X 155276211-155334657 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047381, HPA060101 Uncertain Approved Plasma membrane Mixed spleen: 63.7 CLIC3 ENSG00000169583 Chloride intracellular channel 3 9 136994635-136996803 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005963 Approved Supported Nuclear bodies Tissue enhanced 0 esophagus: 87.1;thyroid gland: 85.5 skin: 43.6 CLIC4 CLIC4L, DKFZP566G223, H1, huH1, P64H1 ENSG00000169504 Chloride intracellular channel 4 1 24745357-24844324 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008019, HPA060804 Supported Supported Cytosol Expressed in all smooth muscle: 393.9 CLIC5 DFNB102 ENSG00000112782 Chloride intracellular channel 5 6 45898451-46080395 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA074371 Supported Nuclear speckles
Plasma membrane Tissue enhanced 0 lung: 116.4;skeletal muscle: 119.2 heart muscle: 72.3 CLIC6 CLIC1L, CLIC5 ENSG00000159212 Chloride intracellular channel 6 21 34669389-34718227 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055123, HPA065285 Approved Tissue enhanced 0 stomach: 76.8 cervix: 24.3 CLNS1A CLCI, ICln ENSG00000074201 Chloride channel, nucleotide-sensitive, 1A 11 77514936-77637805 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017840, HPA031707, HPA031708, HPA032045 Approved Supported Nucleus
Microtubules
Cytosol Expressed in all thyroid gland: 131.3 CMTM1 CKLFH, CKLFH1a, CKLFSF1 ENSG00000089505 CKLF-like MARVEL transmembrane domain containing 1 16 66566393-66579137 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA013801, HPA017136 Uncertain Approved Nucleoplasm Tissue enriched 6 testis: 28.8 spleen: 4.5 CMTM7 CKLFSF7, FLJ30992 ENSG00000153551 CKLF-like MARVEL transmembrane domain containing 7 3 32391671-32483067 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA077409 Approved Plasma membrane Mixed fallopian tube: 60.9 CNGA1 CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49 ENSG00000198515 Cyclic nucleotide gated channel alpha 1 4 47935977-48016672 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA076168 Approved Vesicles
Plasma membrane Mixed liver: 14.2 CNGA3 ACHM2, CCNC1, CCNCa, CNCG3, CNG3 ENSG00000144191 Cyclic nucleotide gated channel alpha 3 2 98346155-98398601 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed esophagus: 1.9 CNGB1 CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45 ENSG00000070729 Cyclic nucleotide gated channel beta 1 16 57882340-57971116 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039159, HPA060355 Uncertain Approved Vesicles
Cytosol Mixed appendix: 1.6 CSE1L CAS, CSE1, XPO2 ENSG00000124207 CSE1 chromosome segregation 1-like (yeast) 20 49046246-49096960 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002140, HPA038059, HPA038060 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 158.9 CSTB CST6, EPM1, PME, STFB ENSG00000160213 Cystatin B (stefin B) 21 43772512-43776445 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017380, CAB047320, HPA058557 Supported Supported Nucleoli
Cytosol Tissue enriched 8 esophagus: 1836.3 tonsil: 237.3 CTIF KIAA0427 ENSG00000134030 CBP80/20-dependent translation initiation factor 18 48539046-48863217 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016865, HPA024801 Uncertain Supported Cytosol Mixed cerebral cortex: 24.9 DCD AIDD, DCD-1, DSEP, HCAP, PIF ENSG00000161634 Dermcidin 12 54644591-54648493 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063967 Supported Tissue enriched 94 breast: 332.5 skeletal muscle: 3.5 DDX19A DDX19L, FLJ11126 ENSG00000168872 DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A 16 70346829-70373383 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045252, HPA066668 Approved Uncertain Nucleoplasm Expressed in all parathyroid gland: 50.2 DDX19B DBP5, DDX19 ENSG00000157349 DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B 16 70289663-70335283 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037229, CAB037284, HPA046380, HPA066668 Approved Uncertain Nucleoplasm Expressed in all testis: 82.7 DDX3X DBX, DDX14, DDX3, HLP2 ENSG00000215301 DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked X 41333348-41364472 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001648, HPA005631, HPA059585 Supported Approved Approved Nucleus
Cytosol Expressed in all parathyroid gland: 270.3 DEFA1 DEF1, DEFA2, HNP-1, MRS ENSG00000206047 Defensin, alpha 1 8 6977649-6980080 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB032548, HPA052517 Supported Tissue enriched 284 bone marrow: 15680.7 skin: 55.3 DEFA1B ENSG00000240247 Defensin, alpha 1B 8 6996766-7018289 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052517 Supported Tissue enriched 514 bone marrow: 61211.3 skin: 119.2 DEFA6 DEF6, HD-6 ENSG00000164822 Defensin, alpha 6, Paneth cell-specific 8 6924693-6926076 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019462 Supported Group enriched 521 duodenum: 5909.3;small intestine: 10744.7 colon: 15.9 DEFB1 BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822 ENSG00000164825 Defensin, beta 1 8 6870575-6878022 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cervix, uterine: 614.0;kidney: 1487.1 salivary gland: 233.8 DEFB103A DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3 ENSG00000176797 Defensin, beta 103A 8 7881204-7882664 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 tonsil: 2.2 skin: 0.8 DEFB103B ENSG00000177243 Defensin, beta 103B 8 7428888-7430348 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 tonsil: 2.2 skin: 0.8 DEFB4A DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1 ENSG00000171711 Defensin, beta 4A 8 7894629-7896711 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 esophagus: 6.0;gallbladder: 10.4;tonsil: 12.8 cervix: 1.1 DEFB4B DEFB4P ENSG00000177257 Defensin, beta 4B 8 7414860-7416863 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 20 tonsil: 2.8 skin: 0.1 DUX4 ENSG00000260596 Double homeobox 4 4 190173774-190185942 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA058451 Approved Nucleus
Nucleoli
Cytosol Tissue enhanced 0 testis: 1.5 seminal vesicle: 0.5 DYSF FER1L1, LGMD2B ENSG00000135636 Dysferlin 2 71453722-71686768 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002510, HPA017071, HPA021945 Supported Supported Plasma membrane
Microtubule organizing center Mixed skeletal muscle: 32.8 EIF5A EIF-5A, EIF5A1, MGC104255, MGC99547 ENSG00000132507 Eukaryotic translation initiation factor 5A 17 7306999-7312463 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005042, HPA061298 Approved Validated Nucleoplasm
Cytosol Expressed in all esophagus: 437.6 EIF5A2 ENSG00000163577 Eukaryotic translation initiation factor 5A2 3 170888415-170908693 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029090 Approved Supported Vesicles Tissue enhanced 0 testis: 36.4 smooth muscle: 10.2 EIF5AL1 bA342M3.3, EIF5AP1 ENSG00000253626 Eukaryotic translation initiation factor 5A-like 1 10 79512601-79516440 Predicted intracellular proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 10 testis: 20.0 parathyroid gland: 2.0 ENY2 DC6, FLJ20480, Sus1 ENSG00000120533 Enhancer of yellow 2 homolog (Drosophila) 8 109334324-109345953 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024648 Approved Approved Nucleoplasm
Mitochondria Expressed in all kidney: 77.0 ERBB4 ALS19, HER4 ENSG00000178568 Erb-b2 receptor tyrosine kinase 4 2 211375717-212538841 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB000276, HPA012016, CAB025522 Approved Tissue enhanced 0 fallopian tube: 17.6 cerebral cortex: 7.6 ERVW-1 ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW ENSG00000242950 Endogenous retrovirus group W, member 1 7 92468380-92477986 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 11 placenta: 77.1 testis: 6.7 FAM26D C6orf78, FLJ32239 ENSG00000164451 Family with sequence similarity 26, member D 6 116529013-116558868 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 46 placenta: 33.6 testis: 0.7 FXYD2 ATP1G1, HOMG2, MGC12372 ENSG00000137731 FXYD domain containing ion transport regulator 2 11 117800844-117828698 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064218, HPA068838 Supported Approved Mitochondria Group enriched 6 gallbladder: 575.2;kidney: 1428.7;salivary gland: 383.4 pancreas: 134.6 FXYD5 OIT2 ENSG00000089327 FXYD domain containing ion transport regulator 5 19 35154730-35169883 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010817 Uncertain Approved Endoplasmic reticulum Expressed in all spleen: 241.4 FXYD6 ENSG00000137726 FXYD domain containing ion transport regulator 6 11 117836976-117877486 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041334, HPA042284 Approved Approved Nucleoplasm
Cytosol Expressed in all cerebral cortex: 698.7 GABARAP ATG8A, MM46 ENSG00000170296 GABA(A) receptor-associated protein 17 7240014-7242770 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065883 Approved Vesicles Expressed in all epididymis: 750.2 GABRA1 EJM5 ENSG00000022355 Gamma-aminobutyric acid (GABA) A receptor, alpha 1 5 161847191-161899981 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022502, HPA055746 Supported Tissue enriched 44 cerebral cortex: 109.1 adrenal gland: 2.4 GABRA2 ENSG00000151834 Gamma-aminobutyric acid (GABA) A receptor, alpha 2 4 46248427-46475230 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 6 cerebral cortex: 74.5 epididymis: 13.3 GABRB2 ENSG00000145864 Gamma-aminobutyric acid (GABA) A receptor, beta 2 5 161288429-161549044 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001964, HPA067632 Supported Tissue enriched 11 cerebral cortex: 63.0 epididymis: 5.5 GABRB3 ENSG00000166206 Gamma-aminobutyric acid (GABA) A receptor, beta 3 15 26543546-26939539 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 80.1 gallbladder: 21.9 GABRG2 ENSG00000113327 Gamma-aminobutyric acid (GABA) A receptor, gamma 2 5 162067540-162155536 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 9 cerebral cortex: 74.3 adrenal gland: 8.2 GAP43 B-50, PP46 ENSG00000172020 Growth associated protein 43 3 115623324-115721490 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004417, HPA013392, HPA015600 Supported Validated Plasma membrane Tissue enriched 37 cerebral cortex: 346.9 appendix: 9.4 GJA3 CX46, CZP3 ENSG00000121743 Gap junction protein, alpha 3, 46kDa 13 20138255-20161049 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA014821 Supported Tissue enhanced 0 heart muscle: 4.7;parathyroid gland: 5.8;placenta: 3.5 testis: 2.5 GJA4 CX37 ENSG00000187513 Gap junction protein, alpha 4, 37kDa 1 34792998-34795747 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA047981 Approved Tissue enhanced 0 placenta: 88.6 fallopian tube: 47.8 GJA8 CAE, CAE1, CX50, CZP1 ENSG00000121634 Gap junction protein, alpha 8, 50kDa 1 147907956-147909257 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 91 testis: 12.0 smooth muscle: 0.1 GJB1 CMTX, CMTX1, CX32 ENSG00000169562 Gap junction protein, beta 1, 32kDa X 71215194-71225516 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB012994 Uncertain Tissue enhanced 0 liver: 159.3 gallbladder: 59.5 GJB2 CX26, DFNA3, DFNB1, NSRD1 ENSG00000165474 Gap junction protein, beta 2, 26kDa 13 20187470-20192898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013093, HPA014362 Uncertain Approved Mitochondria Tissue enriched 9 esophagus: 728.4 tonsil: 84.8 GJC1 CX45, GJA7 ENSG00000182963 Gap junction protein, gamma 1, 45kDa 17 44798448-44830816 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071788 Uncertain Nucleoli
Cell Junctions
Cytosol Tissue enhanced 0 endometrium: 43.9;placenta: 50.9;smooth muscle: 48.2 seminal vesicle: 27.0 GJC3 CX30.2, GJE1 ENSG00000176402 Gap junction protein, gamma 3, 30.2kDa 7 99923269-99929620 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015024 Uncertain Tissue enhanced 0 breast: 8.9;prostate: 5.6 testis: 3.2 GJD4 CX40.1, FLJ90023 ENSG00000177291 Gap junction protein, delta 4, 40.1kDa 10 35605410-35608935 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038266 Approved Mixed cerebral cortex: 1.7 GLE1 GLE1L, hGLE1, LCCS1 ENSG00000119392 GLE1 RNA export mediator 9 128504700-128542288 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041689, HPA043538, HPA061560 Supported Supported Nuclear membrane
Nucleoli Expressed in all testis: 58.6 GLRA1 STHE ENSG00000145888 Glycine receptor, alpha 1 5 151822513-151924842 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level HPA016502 Uncertain Not detected adrenal gland: 0.4 GLRA2 GLR ENSG00000101958 Glycine receptor, alpha 2 X 14529298-14731812 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB070422 Approved Group enriched 10 cerebral cortex: 6.2;colon: 1.4;rectum: 4.3 testis: 0.3 GLRA3 ENSG00000145451 Glycine receptor, alpha 3 4 174636914-174829314 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 breast: 2.6;cerebral cortex: 9.1 adrenal gland: 1.0 GLRB ENSG00000109738 Glycine receptor, beta 4 157076057-157172090 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052363 Approved Tissue enhanced 0 cerebral cortex: 62.2;parathyroid gland: 62.0 cervix: 14.0 GNLY D2S69E, LAG-2, LAG2, NKG5, TLA519 ENSG00000115523 Granulysin 2 85685175-85698854 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025186, HPA058021 Supported Tissue enhanced 0 bone marrow: 153.1;endometrium: 113.5;spleen: 114.5 lung: 51.2 GRIA2 GluA2, GLUR2, GLURB ENSG00000120251 Glutamate receptor, ionotropic, AMPA 2 4 157204182-157366075 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006830, CAB007812, HPA008441, CAB012981 Supported Tissue enriched 8 cerebral cortex: 207.2 endometrium: 27.2 GRIA3 GluA3, GLUR3, GLURC, MRX94 ENSG00000125675 Glutamate receptor, ionotropic, AMPA 3 X 123184153-123490915 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058659 Uncertain Tissue enhanced 0 cerebral cortex: 56.8 adrenal gland: 11.4 GRIK4 GluK4, GRIK, KA1 ENSG00000149403 Glutamate receptor, ionotropic, kainate 4 11 120511759-120988904 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 10.6 thyroid gland: 2.8 GRIN1 GluN1, NMDAR1 ENSG00000176884 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 9 137138390-137168762 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB006831 Approved Tissue enriched 202 cerebral cortex: 152.3 prostate: 0.7 GRIN2C GluN2C, NMDAR2C ENSG00000161509 Glutamate receptor, ionotropic, N-methyl D-aspartate 2C 17 74842023-74861504 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 9.6;heart muscle: 7.8;thyroid gland: 14.0 salivary gland: 4.4 HCN2 BCNG-2, BCNG2, HAC-1 ENSG00000099822 Hyperpolarization activated cyclic nucleotide gated potassium channel 2 19 589893-617159 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 cerebral cortex: 38.5;heart muscle: 8.1 testis: 3.4 HCN4 ENSG00000138622 Hyperpolarization activated cyclic nucleotide gated potassium channel 4 15 73319859-73369264 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 1.4;heart muscle: 1.9;testis: 6.7 adrenal gland: 0.5 HSPA1A HSP70-1, HSPA1 ENSG00000204389 Heat shock 70kDa protein 1A 6 31815464-31817946 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB017451, CAB032815, HPA052504 Supported Uncertain Nucleoplasm
Vesicles Mixed adrenal gland: 49.9 HSPA1B HSP70-2 ENSG00000204388 Heat shock 70kDa protein 1B 6 31827735-31830255 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB008640, HPA052504 Approved Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 34.3 urinary bladder: 15.0 HTN3 HIS2 ENSG00000205649 Histatin 3 4 70028413-70036538 Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB073541 Supported Uncertain Vesicles Tissue enriched 1662 salivary gland: 47809.1 ovary: 28.7 HTR3A 5-HT3A, 5-HT3R, HTR3 ENSG00000166736 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 11 113974881-113990313 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 5 appendix: 2.9;lymph node: 7.9;tonsil: 7.4 small intestine: 1.1 HTR3D ENSG00000186090 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic 3 184031544-184039369 Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.0 HVCN1 Hv1, MGC15619, VSOP ENSG00000122986 Hydrogen voltage gated channel 1 12 110627841-110704950 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039329 Approved Mixed testis: 82.3 IPO11 RanBP11 ENSG00000086200 Importin 11 5 62403972-62628582 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067097 Approved Validated Nucleus
Nucleoli fibrillar center Expressed in all testis: 40.5 IPO13 IMP13, KIAA0724, RANBP13 ENSG00000117408 Importin 13 1 43946939-43968022 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB070425 Uncertain Expressed in all testis: 66.5 IPO4 FLJ23338, Imp4 ENSG00000196497 Importin 4 14 24180219-24188964 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039043, HPA064572 Uncertain Approved Cytosol Tissue enhanced 0 testis: 16.9 skin: 5.3 IPO5 IMB3, KPNB3, MGC2068, Pse1, RANBP5 ENSG00000065150 Importin 5 13 97953658-98024297 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009110, HPA040983, HPA056548 Approved Supported Nucleoplasm
Cytosol Expressed in all testis: 382.6 IPO7 Imp7, RANBP7 ENSG00000205339 Importin 7 11 9384622-9448126 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019002, HPA056590 Approved Approved Validated Nucleoplasm
Cytosol Expressed in all thyroid gland: 89.6 IPO8 IMP8, RANBP8 ENSG00000133704 Importin 8 12 30628988-30695986 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018439, HPA023765 Uncertain Supported Nucleus Expressed in all parathyroid gland: 119.5 IPO9 FLJ10402, Imp9 ENSG00000198700 Importin 9 1 201829141-201884294 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059540 Approved Vesicles
Cytosol Expressed in all parathyroid gland: 30.0 ITPR1 ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29 ENSG00000150995 Inositol 1,4,5-trisphosphate receptor, type 1 3 4493348-4847840 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014765, HPA016487 Approved Approved Vesicles Tissue enhanced 0 parathyroid gland: 104.9 thyroid gland: 47.2 KCNA2 HK4, Kv1.2 ENSG00000177301 Potassium channel, voltage gated shaker related subfamily A, member 2 1 110593580-110631474 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001976 Supported Tissue enriched 5 cerebral cortex: 20.7 thyroid gland: 3.8 KCNA3 HLK3, HPCN3, Kv1.3, MK3 ENSG00000177272 Potassium channel, voltage gated shaker related subfamily A, member 3 1 110672465-110675033 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016625 Approved Mixed lymph node: 10.7 KCNA5 HK2, HPCN1, Kv1.5 ENSG00000130037 Potassium channel, voltage gated shaker related subfamily A, member 5 12 5043989-5046788 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021516, CAB022562 Approved Tissue enhanced 0 heart muscle: 20.8 esophagus: 5.6 KCNB1 Kv2.1 ENSG00000158445 Potassium channel, voltage gated Shab related subfamily B, member 1 20 49363877-49484297 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supported Tissue enhanced 0 adipose tissue: 11.0;cerebral cortex: 21.0 fallopian tube: 7.5 KCNC3 Kv3.3, SCA13 ENSG00000131398 Potassium channel, voltage gated Shaw related subfamily C, member 3 19 50311937-50333515 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018041 Uncertain Tissue enhanced 0 parathyroid gland: 39.3 cerebral cortex: 19.9 KCND2 KIAA1044, Kv4.2, RK5 ENSG00000184408 Potassium channel, voltage gated Shal related subfamily D, member 2 7 120273668-120750331 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029068 Approved Tissue enhanced 0 cerebral cortex: 20.8 gallbladder: 6.9 KCND3 KSHIVB, Kv4.3, SCA19, SCA22 ENSG00000171385 Potassium channel, voltage gated Shal related subfamily D, member 3 1 111770662-111989155 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029452 Approved Mixed cerebral cortex: 26.8 KCNF1 IK8, KCNF, kH1, Kv5.1 ENSG00000162975 Potassium channel, voltage gated modifier subfamily F, member 1 2 10911937-10914225 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB004678, HPA014738 Supported Approved Golgi apparatus Tissue enriched 32 cerebral cortex: 37.6 endometrium: 1.1 KCNH1 eag, eag1, h-eag, Kv10.1 ENSG00000143473 Potassium channel, voltage gated eag related subfamily H, member 1 1 210678315-211134115 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014551, HPA019445 Supported Approved Vesicles Tissue enriched 12 cerebral cortex: 11.5 testis: 0.9 KCNH2 erg1, HERG, Kv11.1, LQT2 ENSG00000055118 Potassium channel, voltage gated eag related subfamily H, member 2 7 150944961-150978315 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 bone marrow: 24.1;testis: 27.4 parathyroid gland: 12.9 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium channel, voltage gated eag related subfamily H, member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Approved Nucleus
Mitochondria Group enriched 5 cerebral cortex: 24.3;fallopian tube: 7.1;parathyroid gland: 4.9 adrenal gland: 2.2 KCNJ1 Kir1.1, ROMK1 ENSG00000151704 Potassium channel, inwardly rectifying subfamily J, member 1 11 128836315-128867373 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA026962 Supported Tissue enriched 118 kidney: 209.0 epididymis: 1.7 KCNJ13 Kir1.4, Kir7.1, LCA16 ENSG00000115474 Potassium channel, inwardly rectifying subfamily J, member 13 2 232766464-232776568 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 parathyroid gland: 25.4;small intestine: 114.2 thyroid gland: 12.5 KCNJ16 BIR9, Kir5.1 ENSG00000153822 Potassium channel, inwardly rectifying subfamily J, member 16 17 70053429-70135608 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA059563 Approved Uncertain Vesicles Group enriched 7 kidney: 207.9;parathyroid gland: 268.8;thyroid gland: 233.9 seminal vesicle: 31.9 KCNJ2 IRK1, Kir2.1, LQT7 ENSG00000123700 Potassium channel, inwardly rectifying subfamily J, member 2 17 70168673-70180048 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA029109 Approved Tissue enhanced 0 parathyroid gland: 46.5 fallopian tube: 11.6 KCNJ3 GIRK1, KGA, Kir3.1 ENSG00000162989 Potassium channel, inwardly rectifying subfamily J, member 3 2 154698299-154858352 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024231 Uncertain Tissue enhanced 0 cerebral cortex: 25.5;parathyroid gland: 39.5 seminal vesicle: 14.1 KCNJ5 CIR, GIRK4, KATP1, Kir3.4, LQT13 ENSG00000120457 Potassium channel, inwardly rectifying subfamily J, member 5 11 128891356-128921035 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014722, HPA017353, CAB022569 Supported Tissue enhanced 0 adrenal gland: 85.2 spleen: 19.1 KCNJ6 BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2 ENSG00000157542 Potassium channel, inwardly rectifying subfamily J, member 6 21 37607376-37916446 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 7 cerebral cortex: 2.6 epididymis: 0.3 KCNJ8 Kir6.1 ENSG00000121361 Potassium channel, inwardly rectifying subfamily J, member 8 12 21764955-21775581 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031066 Uncertain Mixed seminal vesicle: 31.6 KCNK15 dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5 ENSG00000124249 Potassium channel, two pore domain subfamily K, member 15 20 44745780-44752313 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA064861 Uncertain Tissue enhanced 0 fallopian tube: 8.0 testis: 2.9 KCNK16 K2p16.1, TALK-1, TALK1 ENSG00000095981 Potassium channel, two pore domain subfamily K, member 16 6 39314698-39322968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 duodenum: 3.9;pancreas: 5.4;stomach: 12.6 thyroid gland: 1.7 KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, two pore domain subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043892 Uncertain Tissue enhanced 0 lung: 5.6 placenta: 5.2 KCNK3 K2p3.1, TASK, TASK-1 ENSG00000171303 Potassium channel, two pore domain subfamily K, member 3 2 26692690-26733420 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 112.3;placenta: 35.5 lung: 19.9 KCNK5 K2p5.1, TASK-2 ENSG00000164626 Potassium channel, two pore domain subfamily K, member 5 6 39188973-39229450 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059148 Uncertain Approved Nucleus Tissue enhanced 0 small intestine: 40.1 gallbladder: 29.6 KCNK6 K2p6.1, TWIK-2 ENSG00000099337 Potassium channel, two pore domain subfamily K, member 6 19 38319844-38332076 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB022637, HPA040184 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Mixed endometrium: 22.8 KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, two pore domain subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 adrenal gland: 4.8;cerebral cortex: 4.8 cervix: 0.7 KCNN2 hSK2, KCa2.2 ENSG00000080709 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 5 114360945-114496500 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038221 Uncertain Uncertain Nucleoplasm
Cytosol Tissue enhanced 0 adrenal gland: 27.4;prostate: 18.5 liver: 15.9 KCNN4 hIKCa1, hKCa4, hSK4, IK, KCa3.1 ENSG00000104783 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 19 43766533-43781257 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053841, HPA059622 Approved Tissue enhanced 0 salivary gland: 74.3 stomach: 37.1 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium channel, voltage gated KQT-like subfamily Q, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supported Tissue enhanced 0 adrenal gland: 134.2;thyroid gland: 102.8 seminal vesicle: 60.3 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium channel, voltage gated KQT-like subfamily Q, member 2 20 63400210-63472677 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Approved Approved Endoplasmic reticulum Tissue enriched 7 cerebral cortex: 56.3 adrenal gland: 8.2 KCNQ3 EBN2, Kv7.3 ENSG00000184156 Potassium channel, voltage gated KQT-like subfamily Q, member 3 8 132120859-132480953 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 14 cerebral cortex: 26.9 adrenal gland: 1.9 KCNQ4 DFNA2, Kv7.4 ENSG00000117013 Potassium channel, voltage gated KQT-like subfamily Q, member 4 1 40784012-40840452 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018305 Uncertain Mixed smooth muscle: 2.5 KCNS1 Kv9.1 ENSG00000124134 Potassium voltage-gated channel, modifier subfamily S, member 1 20 45092310-45101112 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 9.3;gallbladder: 3.8;seminal vesicle: 4.2 testis: 1.7 KCNS2 Kv9.2 ENSG00000156486 Potassium voltage-gated channel, modifier subfamily S, member 2 8 98427022-98432848 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA051417 Uncertain Tissue enhanced 0 cerebral cortex: 7.2 placenta: 2.2 KCNS3 Kv9.3 ENSG00000170745 Potassium voltage-gated channel, modifier subfamily S, member 3 2 17877847-18361616 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA014864 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 lung: 35.5 skeletal muscle: 29.6 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KCNT2 KCa4.2, SLICK, SLO2.1 ENSG00000162687 Potassium channel, sodium activated subfamily T, member 2 1 196225779-196609225 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051218 Uncertain Approved Vesicles Tissue enhanced 0 ovary: 6.0 cerebral cortex: 3.5 KPNA1 IPOA5, NPI-1, RCH2, SRP1 ENSG00000114030 Karyopherin alpha 1 (importin alpha 5) 3 122421949-122514945 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053627, HPA063426 Supported Validated Nucleus
Cytosol Expressed in all cerebral cortex: 39.5 KPNA2 IPOA1, QIP2, RCH1, SRP1alpha ENSG00000182481 Karyopherin alpha 2 (RAG cohort 1, importin alpha 1) 17 68035519-68046842 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015460, HPA041270 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 347.6 KPNA3 hSRP1, IPOA4, SRP1gamma, SRP4 ENSG00000102753 Karyopherin alpha 3 (importin alpha 4) 13 49699307-49792921 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046852 Approved Approved Nucleoplasm
Cytosol Expressed in all testis: 49.6 KPNA4 IPOA3, MGC12217, MGC26703, QIP1, SRP3 ENSG00000186432 Karyopherin alpha 4 (importin alpha 3) 3 160494995-160565588 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034336, HPA043154, HPA045500 Supported Validated Nucleus Expressed in all skeletal muscle: 36.6 KPNA5 IPOA6, SRP6 ENSG00000196911 Karyopherin alpha 5 (importin alpha 6) 6 116681187-116741866 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026464, HPA054037 Supported Supported Cytosol Tissue enhanced 0 testis: 83.1 ovary: 23.5 KPNA6 FLJ11249, IPOA7, KPNA7, MGC17918 ENSG00000025800 Karyopherin alpha 6 (importin alpha 7) 1 32108038-32176568 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018863 Supported Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 48.5 KPNB1 IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97 ENSG00000108424 Karyopherin (importin) beta 1 17 47649476-47685505 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029878, CAB034449, HPA050302 Supported Supported Nucleoplasm
Nuclear membrane
Cytosol Expressed in all testis: 218.3 LBP BPIFD2 ENSG00000129988 Lipopolysaccharide binding protein 20 38346356-38377023 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001508, CAB025905 Approved Group enriched 5 adipose tissue: 68.5;liver: 264.3 appendix: 31.9 LHFPL5 DFNB67, dJ510O8.8, MGC33835, Tmhs ENSG00000197753 Lipoma HMGIC fusion partner-like 5 6 35805293-35833874 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA055110 Uncertain Tissue enhanced 0 epididymis: 12.0 bone marrow: 4.2 LRRC8A FLJ10337, KIAA1437, LRRC8, SWELL1 ENSG00000136802 Leucine rich repeat containing 8 family, member A 9 128882112-128918039 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all cerebral cortex: 89.9 LRRC8B KIAA0231, TA-LRRP ENSG00000197147 Leucine rich repeat containing 8 family, member B 1 89524836-89597864 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017950 Uncertain Approved Nuclear speckles Tissue enhanced 0 cerebral cortex: 38.3 testis: 30.6 LRRC8C AD158 ENSG00000171488 Leucine rich repeat containing 8 family, member C 1 89633072-89769903 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029347 Uncertain Approved Golgi apparatus Mixed smooth muscle: 22.4 LRRC8D FLJ10470, LRRC5 ENSG00000171492 Leucine rich repeat containing 8 family, member D 1 89821014-89936611 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014745 Approved Nucleoplasm
Mitochondria Expressed in all cerebral cortex: 36.0 LRRC8E FLJ23420 ENSG00000171017 Leucine rich repeat containing 8 family, member E 19 7888505-7902021 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020466 Uncertain Mixed skin: 11.2 MAGT1 DKFZp564K142, IAP, MRX95, OST3B ENSG00000102158 Magnesium transporter 1 X 77826364-77895593 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049851 Approved Expressed in all thyroid gland: 136.9 MARVELD3 MRVLDC3 ENSG00000140832 MARVEL domain containing 3 16 71626161-71642114 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA043514, HPA045471 Approved Vesicles
Intermediate filaments Tissue enhanced 0 small intestine: 37.8 duodenum: 32.4 MCM3AP GANP, KIAA0572, Map80, SAC3 ENSG00000160294 Minichromosome maintenance complex component 3 associated protein 21 46235126-46286297 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021527, HPA032103 Approved Supported Nucleus
Nuclear membrane
Cytosol Expressed in all parathyroid gland: 35.1 MCOLN1 ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1 ENSG00000090674 Mucolipin 1 19 7522626-7534009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031763, CAB032637 Uncertain Supported Plasma membrane
Cytosol Expressed in all spleen: 49.0 MCOLN2 FLJ36691, TRP-ML2, TRPML2 ENSG00000153898 Mucolipin 2 1 84925583-84997113 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA019114, HPA048999 Uncertain Supported Intermediate filaments Mixed rectum: 17.6 MCOLN3 FLJ11006, TRP-ML3, TRPML3 ENSG00000055732 Mucolipin 3 1 85018082-85048499 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018106, HPA062137 Approved Approved Nucleoli
Cytosol Tissue enhanced 0 adrenal gland: 57.9;parathyroid gland: 42.1 epididymis: 17.3 MMD MMA, PAQR11 ENSG00000108960 Monocyte to macrophage differentiation-associated 17 55392613-55421992 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026978 Approved Vesicles Tissue enhanced 0 adipose tissue: 141.1 cerebral cortex: 73.3 MPEG1 MPG1 ENSG00000197629 Macrophage expressed 1 11 59208510-59212951 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046801 Approved Tissue enhanced 0 spleen: 287.6 appendix: 156.3 MRLN LINC00948, M1, MLN, MUSER1 ENSG00000227877 Myoregulin 10 59736692-59756041 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 skeletal muscle: 65.4 kidney: 14.4 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supported Group enriched 15 appendix: 249.3;lymph node: 780.6;spleen: 476.2;tonsil: 821.5 urinary bladder: 39.8 MS4A10 CD20L7, MS4A9 ENSG00000172689 Membrane-spanning 4-domains, subfamily A, member 10 11 60785348-60801305 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014778 Uncertain Group enriched 93 duodenum: 76.3;small intestine: 97.7 parathyroid gland: 0.9 MS4A14 DKFZp434H092, FLJ32856, MS4A16, NYD-SP21 ENSG00000166928 Membrane-spanning 4-domains, subfamily A, member 14 11 60378530-60417756 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 12 testis: 91.2 spleen: 7.7 MVP LRP, VAULT1 ENSG00000013364 Major vault protein 16 29820394-29848039 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002321, CAB002752, CAB022717, HPA064740 Supported Validated Cytosol Expressed in all small intestine: 169.1 MX2 MXB ENSG00000183486 MX dynamin-like GTPase 2 21 41361943-41409390 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030235 Uncertain Mixed spleen: 46.7 MYADM ENSG00000179820 Myeloid-associated differentiation marker 19 53866223-53876437 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056301 Approved Nuclear speckles Expressed in all smooth muscle: 257.6 MYO1C myr2 ENSG00000197879 Myosin IC 17 1464098-1492812 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001768, HPA005924, CAB037023 Supported Validated Nuclear bodies
Plasma membrane Expressed in all adipose tissue: 191.9 NALCN bA430M15.1, CanIon, VGCNL1 ENSG00000102452 Sodium leak channel, non selective 13 101053776-101416492 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031889, HPA031890, HPA031958 Approved Tissue enhanced 0 cerebral cortex: 28.2 adrenal gland: 6.0 NDC1 FLJ10407, NET3, TMEM48 ENSG00000058804 NDC1 transmembrane nucleoporin 1 53765460-53838860 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069751, HPA070882 Approved Supported Nuclear membrane
Plasma membrane
Actin filaments Mixed lymph node: 16.6 NEK6 SID6-1512 ENSG00000119408 NIMA-related kinase 6 9 124257606-124353307 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB045993, HPA056828 Approved Supported Nucleoplasm
Microtubule organizing center
Cytosol Expressed in all appendix: 45.6 NEK7 ENSG00000151414 NIMA-related kinase 7 1 198156963-198322420 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015520, HPA018193 Approved Supported Nucleoplasm Expressed in all heart muscle: 88.6 NEK9 DKFZp434D0935, MGC16714, Nek8, NERCC ENSG00000119638 NIMA-related kinase 9 14 75079353-75127344 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001405 Approved Approved Mitochondria Expressed in all parathyroid gland: 30.1 NPAP1 C15orf2 ENSG00000185823 Nuclear pore associated protein 1 15 24675868-24683393 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA018828, HPA019562 Uncertain Tissue enriched 11 testis: 5.3 skin: 0.4 NPIPA1 morpheus, NPIP ENSG00000183426 Nuclear pore complex interacting protein family, member A1 16 14750813-14952060 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA053611 Supported Approved Nucleoplasm Mixed ovary: 68.2 NPPC CNP ENSG00000163273 Natriuretic peptide C 2 231921820-231926403 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA035362 Uncertain Tissue enhanced 0 prostate: 5.7 appendix: 3.0 NSF SKD2 ENSG00000073969 N-ethylmaleimide-sensitive factor 17 46590669-46757464 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003154, CAB009324, CAB013645, HPA071089 Approved Supported Cytosol Tissue enriched 5 cerebral cortex: 134.7 parathyroid gland: 25.1 NUP107 NUP84 ENSG00000111581 Nucleoporin 107kDa 12 68686734-68745809 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024141, HPA031679 Uncertain Supported Nucleoplasm
Centrosome Expressed in all testis: 38.0 NUP133 FLJ10814 ENSG00000069248 Nucleoporin 133kDa 1 229440260-229508341 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059767 Approved Supported Nuclear membrane Expressed in all parathyroid gland: 32.5 NUP153 HNUP153 ENSG00000124789 Nucleoporin 153kDa 6 17615035-17706834 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027896, HPA027897, HPA027898 Supported Validated Nuclear membrane Expressed in all testis: 53.3 NUP155 KIAA0791, N155 ENSG00000113569 Nucleoporin 155kDa 5 37288137-37371181 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037775 Uncertain Validated Nuclear membrane Tissue enriched 9 testis: 126.2 parathyroid gland: 14.1 NUP160 FLJ22583, KIAA0197 ENSG00000030066 Nucleoporin 160kDa 11 47778087-47848555 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all parathyroid gland: 38.8 NUP188 KIAA0169 ENSG00000095319 Nucleoporin 188kDa 9 128947699-129007096 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061750, HPA063942 Approved Supported Nucleus Expressed in all testis: 104.4 NUP205 C7orf14, KIAA0225 ENSG00000155561 Nucleoporin 205kDa 7 135557919-135648757 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024574 Uncertain Expressed in all parathyroid gland: 29.7 NUP210 FLJ22389, GP210, KIAA0906, POM210 ENSG00000132182 Nucleoporin 210kDa 3 13316235-13420309 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA066888 Approved Expressed in all lymph node: 49.2 NUP214 CAIN, CAN, D9S46E, N214 ENSG00000126883 Nucleoporin 214kDa 9 131125561-131234670 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048789 Supported Nucleus
Vesicles
Focal adhesion sites Expressed in all testis: 122.9 NUP35 MP44 ENSG00000163002 Nucleoporin 35kDa 2 183117513-183161680 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018401, HPA018410, HPA018441 Supported Supported Nucleoplasm
Nuclear membrane
Plasma membrane Expressed in all testis: 44.7 NUP37 FLJ22618, MGC5585 ENSG00000075188 Nucleoporin 37kDa 12 102073103-102120124 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056300, HPA073708 Supported Supported Nucleoplasm Expressed in all lymph node: 32.6 NUP43 bA350J20.1, FLJ13287 ENSG00000120253 Nucleoporin 43kDa 6 149724315-149749665 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027126, HPA027291, HPA028500 Approved Expressed in all thyroid gland: 18.6 NUP50 NPAP60L ENSG00000093000 Nucleoporin 50kDa 22 45163841-45188015 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047162, HPA048328 Supported Validated Nucleoplasm
Nuclear membrane Expressed in all testis: 54.5 NUP54 ENSG00000138750 Nucleoporin 54kDa 4 76114659-76148515 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035929, HPA058122 Approved Approved Nucleoplasm Expressed in all testis: 38.9 NUP58 KIAA0410, NUP45, NUPL1 ENSG00000139496 Nucleoporin 58kDa 13 25301524-25349800 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039360 Approved Approved Plasma membrane
Mitochondria
Cytosol Expressed in all testis: 86.6 NUP62 DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI ENSG00000213024 Nucleoporin 62kDa 19 49906825-49929763 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005435, CAB020724 Supported Supported Nuclear membrane
Vesicles Expressed in all testis: 76.8 NUP85 FLJ12549, NUP75 ENSG00000125450 Nucleoporin 85kDa 17 75205659-75235758 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061910, HPA062595 Supported Supported Nucleus
Cytosol Expressed in all testis: 34.1 NUP88 MGC8530 ENSG00000108559 Nucleoporin 88kDa 17 5360963-5420160 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002209, HPA021816 Approved Supported Nucleoplasm Expressed in all testis: 94.1 NUP93 KIAA0095 ENSG00000102900 Nucleoporin 93kDa 16 56730105-56850286 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017937 Uncertain Expressed in all testis: 74.3 NUPL2 CG1, hCG1, H_RG271G13.9, NLP_1 ENSG00000136243 Nucleoporin like 2 7 23181827-23201011 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049036, HPA057251 Validated Nucleus Expressed in all testis: 32.6 ORAI1 CRACM1, FLJ14466, TMEM142A ENSG00000276045 ORAI calcium release-activated calcium modulator 1 12 121626550-121642677 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016583, HPA061823 Approved Supported Cytosol Expressed in all parathyroid gland: 48.9 ORAI3 MGC13024, TMEM142C ENSG00000175938 ORAI calcium release-activated calcium modulator 3 16 30949066-30956461 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015022 Uncertain Approved Nucleoplasm
Cytosol Expressed in all prostate: 26.7 P2RX3 P2X3 ENSG00000109991 Purinergic receptor P2X, ligand gated ion channel, 3 11 57338374-57370600 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057776 Uncertain Tissue enhanced 0 heart muscle: 2.0;testis: 6.1 liver: 0.9 P2RX4 P2X4 ENSG00000135124 Purinergic receptor P2X, ligand gated ion channel, 4 12 121209857-121234106 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039494 Approved Approved Actin filaments
Cytosol Mixed placenta: 33.5 P2RX7 MGC20089, P2X7 ENSG00000089041 Purinergic receptor P2X, ligand gated ion channel, 7 12 121132819-121188032 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034968, HPA042013, HPA044141 Approved Mixed cerebral cortex: 21.1 PANX1 MRS1, PX1, UNQ2529 ENSG00000110218 Pannexin 1 11 94128928-94181972 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016930 Uncertain Validated Plasma membrane Expressed in all testis: 19.4 PANX2 hPANX2, PX2 ENSG00000073150 Pannexin 2 22 50170731-50180294 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA004624, HPA039117 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 8.7 seminal vesicle: 2.1 PANX3 Px3 ENSG00000154143 Pannexin 3 11 124611490-124620356 Predicted membrane proteins, Transporters Evidence at transcript level No evidence Evidence at transcript level Not detected testis: 0.5 PDYN ADCA, PENKB, SCA23 ENSG00000101327 Prodynorphin 20 1978757-1994285 Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049841, HPA053342 Approved Tissue enriched 11 cerebral cortex: 63.5 testis: 5.5 PENK ENSG00000181195 Proenkephalin 8 56436674-56446734 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013138, CAB016390 Supported Group enriched 8 adrenal gland: 568.1;testis: 207.8 prostate: 47.7 PEX11A MGC119947, MGC138534, PEX11-ALPHA ENSG00000166821 Peroxisomal biogenesis factor 11 alpha 15 89677764-89690783 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed prostate: 29.0 PIEZO1 FAM38A, KIAA0233 ENSG00000103335 Piezo-type mechanosensitive ion channel component 1 16 88715343-88785211 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047185 Uncertain Mixed adipose tissue: 42.0 PIEZO2 C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771 ENSG00000154864 Piezo-type mechanosensitive ion channel component 2 18 10666483-11148762 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015986, HPA031974, HPA031975, HPA040616 Approved Approved Vesicles Mixed lung: 12.8 PKD1 PBP, Pc-1, TRPP1 ENSG00000008710 Polycystic kidney disease 1 (autosomal dominant) 16 2088710-2135898 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB046448 Approved Mixed cerebral cortex: 21.6 PKD1L1 PRO19563 ENSG00000158683 Polycystic kidney disease 1 like 1 7 47774652-47948491 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020422, HPA022424 Uncertain Tissue enhanced 0 testis: 2.4 adipose tissue: 1.8 PKD1L3 ENSG00000277481 Polycystic kidney disease 1-like 3 16 71929538-71999978 Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level Evidence at protein level Not detected testis: 0.8 PKD2 Pc-2, PC2, PKD4, TRPP2 ENSG00000118762 Polycystic kidney disease 2 (autosomal dominant) 4 88007668-88077777 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004544, HPA015794 Approved Validated Endoplasmic reticulum Expressed in all endometrium: 100.4 PKD2L1 PCL, PKD2L, PKDL, TRPP3 ENSG00000107593 Polycystic kidney disease 2-like 1 10 100288154-100330486 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022621 Uncertain Tissue enhanced 0 spleen: 10.0 lung: 3.4 PLN CMD1P, PLB ENSG00000198523 Phospholamban 6 118548298-118560730 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005597, HPA026900 Supported Tissue enriched 6 heart muscle: 1486.3 smooth muscle: 266.8 PLP2 A4, A4-LSB, MGC126187 ENSG00000102007 Proteolipid protein 2 (colonic epithelium-enriched) X 49171926-49175239 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042415 Approved Expressed in all skin: 480.7 PLTP BPIFE ENSG00000100979 Phospholipid transfer protein 20 45898621-45912155 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032873 Approved Expressed in all placenta: 630.8 PMP22 GAS3, HNPP, Sp110 ENSG00000109099 Peripheral myelin protein 22 17 15229777-15265326 Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Expressed in all small intestine: 314.4 POM121 DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A ENSG00000196313 POM121 transmembrane nucleoporin 7 72879365-72951440 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003710, HPA043809, HPA049817 Approved Validated Nucleoplasm
Nuclear membrane Expressed in all cerebral cortex: 30.2 PON1 ESA, PON ENSG00000005421 Paraoxonase 1 7 95297676-95324707 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001610 Uncertain Tissue enriched 69 liver: 234.0 adrenal gland: 3.3 PSAP GLBA, SAP1 ENSG00000197746 Prosaposin 10 71816298-71851375 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004426, CAB004647 Supported Supported Vesicles Expressed in all cerebral cortex: 1917.1 PSEN1 AD3, FAD, PS1, S182 ENSG00000080815 Presenilin 1 14 73136418-73223691 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006844, HPA030760, HPA067496 Approved Approved Nucleus
Golgi apparatus
Cell Junctions Expressed in all cerebral cortex: 66.1 PSEN2 AD3L, AD4, PS2, STM2 ENSG00000143801 Presenilin 2 1 226870184-226896105 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013634, HPA038005 Supported Nucleus Expressed in all parathyroid gland: 29.1 PXMP4 PMP24 ENSG00000101417 Peroxisomal membrane protein 4, 24kDa 20 33702754-33720319 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050077 Approved Approved Nucleoli fibrillar center
Peroxisomes Expressed in all parathyroid gland: 29.8 RAE1 Mnrp41 ENSG00000101146 Ribonucleic acid export 1 20 57351010-57379211 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048795 Supported Nucleus
Nucleoli fibrillar center Tissue enriched 6 testis: 182.6 bone marrow: 31.4 RANBP17 ENSG00000204764 RAN binding protein 17 5 170861870-171300015 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029568, HPA029569 Uncertain Approved Nuclear membrane
Nuclear bodies
Cytosol Tissue enhanced 0 testis: 5.0 thyroid gland: 1.7 RANBP2 ADANE, ANE1, NUP358 ENSG00000153201 RAN binding protein 2 2 108719481-108785811 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564 Supported Validated Nuclear membrane
Vesicles Expressed in all parathyroid gland: 73.6 RANGAP1 Fug1, KIAA1835, SD ENSG00000100401 Ran GTPase activating protein 1 22 41245611-41286251 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004293, HPA050110, HPA062034 Supported Validated Nuclear membrane
Vesicles
Cytosol Expressed in all testis: 205.5 REG3A HIP, PAP, PAP1, PBCGF, REG-III, REG3 ENSG00000172016 Regenerating islet-derived 3 alpha 2 79157003-79159753 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047894, HPA048334, HPA060705 Supported Approved Cytosol Group enriched 57 duodenum: 5795.6;small intestine: 8246.6 stomach: 122.9 RHAG CD241, RH50A, SLC42A1 ENSG00000112077 Rh-associated glycoprotein 6 49605158-49636839 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055331 Approved Tissue enriched 24 bone marrow: 73.8 placenta: 3.0 RHBG SLC42A2 ENSG00000132677 Rh family, B glycoprotein (gene/pseudogene) 1 156369212-156385219 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA042726, HPA048489 Approved Approved Nucleoplasm Tissue enhanced 0 kidney: 3.5;ovary: 2.0 liver: 0.6 RHCE CD240CE, RH ENSG00000188672 Rh blood group, CcEe antigens 1 25362249-25430192 Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 6 bone marrow: 28.9 epididymis: 5.1 RHCG C15orf6, PDRC2, RHGK, SLC42A3 ENSG00000140519 Rh family, C glycoprotein 15 89471398-89496613 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041874, HPA043317 Supported Tissue enriched 7 esophagus: 2912.7 tonsil: 436.1 RHD CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI ENSG00000187010 Rh blood group, D antigen 1 25272393-25330445 Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 bone marrow: 9.2 skin: 2.5 RYR1 CCO, MHS, MHS1, PPP1R137, RYR ENSG00000196218 Ryanodine receptor 1 (skeletal) 19 38433699-38587564 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056416 Supported Approved Golgi apparatus
Vesicles
Cytosol Tissue enriched 30 skeletal muscle: 572.4 esophagus: 18.7 RYR2 ARVC2, ARVD2, VTSIP ENSG00000198626 Ryanodine receptor 2 (cardiac) 1 237042205-237833988 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020028 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 9 heart muscle: 68.2 cerebral cortex: 8.0 SAMM50 CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W ENSG00000100347 SAMM50 sorting and assembly machinery component 22 43955421-44010531 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034537 Supported Validated Mitochondria Expressed in all parathyroid gland: 237.7 SCN11A NaN, Nav1.9, SCN12A, SNS-2 ENSG00000168356 Sodium channel, voltage gated, type XI alpha subunit 3 38845769-38950561 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA036746, HPA036747 Uncertain Tissue enhanced 0 placenta: 3.7;spleen: 5.4 testis: 2.1 SCN1A FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI ENSG00000144285 Sodium channel, voltage gated, type I alpha subunit 2 165989160-166128047 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA078664 Approved Nucleoplasm
Nuclear bodies
Plasma membrane Tissue enhanced 0 cerebral cortex: 12.0;fallopian tube: 4.4;lung: 3.2 testis: 2.2 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage gated, type II alpha subunit 2 165239402-165392310 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supported Tissue enriched 22 cerebral cortex: 58.5 kidney: 2.7 SCN4A HYKPP, HYPP, Nav1.4, SkM1 ENSG00000007314 Sodium channel, voltage gated, type IV alpha subunit 17 63938554-63972918 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053992 Approved Nucleoplasm
Microtubule organizing center Group enriched 9 adipose tissue: 12.3;skeletal muscle: 47.2 thyroid gland: 3.3 SCN5A CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1 ENSG00000183873 Sodium channel, voltage gated, type V alpha subunit 3 38548057-38649673 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 18 heart muscle: 26.9 cervix: 1.5 SCN8A CerIII, MED, NaCh6, Nav1.6, PN4 ENSG00000196876 Sodium channel, voltage gated, type VIII alpha subunit 12 51590266-51812864 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022169 Supported Vesicles
Cell Junctions Tissue enriched 6 cerebral cortex: 22.1 testis: 3.5 SCN9A ETHA, Nav1.7, NE-NA, NENA, PN1 ENSG00000169432 Sodium channel, voltage gated, type IX alpha subunit 2 166195185-166375993 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013679, HPA061843 Uncertain Approved Plasma membrane
Actin filaments
Focal adhesion sites Tissue enhanced 0 testis: 9.1 placenta: 5.9 SCNN1A ENaCalpha, SCNN1 ENSG00000111319 Sodium channel, non voltage gated 1 alpha subunit 12 6346843-6377730 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA012743 Supported Mixed cervix: 94.4 SCNN1B ENaCbeta ENSG00000168447 Sodium channel, non voltage gated 1 beta subunit 16 23278231-23381299 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015612 Uncertain Tissue enhanced 0 cervix, uterine: 71.5 esophagus: 45.0 SCNN1D dNaCh, ENaCdelta ENSG00000162572 Sodium channel, non voltage gated 1 delta subunit 1 1280436-1292029 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB009540, HPA026884 Approved Supported Plasma membrane
Actin filaments Tissue enhanced 0 testis: 13.8 cerebral cortex: 7.3 SCNN1G ENaCgamma, SCNEG ENSG00000166828 Sodium channel, non voltage gated 1 gamma subunit 16 23182715-23216883 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA071194 Approved Nucleoplasm
Nucleoli
Plasma membrane Tissue enhanced 0 cervix, uterine: 24.5;kidney: 46.4 thyroid gland: 9.5 SEC13 D3S1231E, npp-20, SEC13L1, SEC13R ENSG00000157020 SEC13 homolog, nuclear pore and COPII coat complex component 3 10293131-10321178 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035292, HPA057943 Approved Supported Nucleoplasm
Vesicles Expressed in all cervix: 119.1 SEH1L SEC13L, Seh1, SEH1A, SEH1B ENSG00000085415 SEH1-like nucleoporin 18 12947133-12987536 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039964 Uncertain Expressed in all cerebral cortex: 34.0 SENP2 AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2 ENSG00000163904 SUMO1/sentrin/SMT3 specific peptidase 2 3 185582496-185633551 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029247, HPA029248 Approved Supported Cytosol Expressed in all testis: 26.8 SIDT1 FLJ20174, SID-1 ENSG00000072858 SID1 transmembrane family, member 1 3 113532296-113629578 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035862 Approved Mixed rectum: 10.7 SIDT2 CGI-40 ENSG00000149577 SID1 transmembrane family, member 2 11 117178733-117197445 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052352 Approved Expressed in all prostate: 59.7 SLC14A1 HsT1341, JK, RACH1, RACH2 ENSG00000141469 Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) 18 45724127-45752520 Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058353, HPA059570 Supported Supported Vesicles Group enriched 5 prostate: 132.1;urinary bladder: 51.9 cerebral cortex: 18.2 SLC14A2 HUT2, UT2 ENSG00000132874 Solute carrier family 14 (urea transporter), member 2 18 45212995-45683686 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 4.0 adipose tissue: 1.7 SLC31A1 COPT1, CTR1, hCTR1 ENSG00000136868 Solute carrier family 31 (copper transporter), member 1 9 113221562-113264492 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013810 Approved Expressed in all liver: 56.5 SLC31A2 COPT2, CTR2, hCTR2 ENSG00000136867 Solute carrier family 31 (copper transporter), member 2 9 113150942-113164137 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014861 Approved Approved Nuclear speckles
Plasma membrane
Intermediate filaments Expressed in all salivary gland: 170.9 SLC41A1 MgtE ENSG00000133065 Solute carrier family 41 (magnesium transporter), member 1 1 205789093-205813748 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014721, HPA015138 Uncertain Approved Mitochondria Tissue enhanced 0 heart muscle: 72.6 testis: 37.3 SLC41A2 DKFZP434K0427 ENSG00000136052 Solute carrier family 41 (magnesium transporter), member 2 12 104802553-104958744 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038658 Approved Mixed liver: 59.8 SLC41A3 FLJ20473 ENSG00000114544 Solute carrier family 41, member 3 3 126006355-126101561 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045847 Approved Supported Plasma membrane Expressed in all testis: 79.0 SLN MGC12301, MGC125854, MGC125855 ENSG00000170290 Sarcolipin 11 107707378-107719693 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011628 Approved Microtubules Tissue enriched 11 skeletal muscle: 2802.5 heart muscle: 263.2 SNAP23 HsT17016, SNAP23A, SNAP23B ENSG00000092531 Synaptosomal-associated protein, 23kDa 15 42491233-42545356 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001214, CAB037083, CAB037317 Approved Supported Plasma membrane Expressed in all spleen: 88.1 SNAP25 bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25 ENSG00000132639 Synaptosomal-associated protein, 25kDa 20 10218830-10307418 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000360, HPA001830 Supported Supported Tissue enriched 31 cerebral cortex: 1764.2 adrenal gland: 57.4 SNAPIN BLOC1S7, BORCS3, SNAPAP ENSG00000143553 SNAP-associated protein 1 153658654-153661830 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046974 Approved Approved Nucleoli
Golgi apparatus Expressed in all fallopian tube: 41.8 SNCA alpha-synuclein, NACP, PARK1, PARK4, PD1 ENSG00000145335 Synuclein, alpha (non A4 component of amyloid precursor) 4 89724099-89838315 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005459, CAB010877 Supported Group enriched 5 bone marrow: 161.2;cerebral cortex: 460.5 endometrium: 56.7 SPAG11B EDDM2B, EP2, EP2C, EP2D, HE2 ENSG00000164871 Sperm associated antigen 11B 8 7442684-7463674 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 5396 epididymis: 6639.3 seminal vesicle: 1.2 SPPL2A IMP3, PSL2 ENSG00000138600 Signal peptide peptidase like 2A 15 50702266-50765808 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036062, HPA067304 Supported Supported Vesicles Expressed in all parathyroid gland: 285.5 STATH STR ENSG00000126549 Statherin 4 69995930-70002570 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044569 Supported Tissue enriched 1726 salivary gland: 45012.6 ovary: 26.0 STIM1 D11S4896E, GOK ENSG00000167323 Stromal interaction molecule 1 11 3854527-4093210 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011088, HPA012123, CAB037128, CAB037288 Supported Validated Endoplasmic reticulum Expressed in all parathyroid gland: 86.3 STIM2 ENSG00000109689 Stromal interaction molecule 2 4 26857678-27025381 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036933, CAB037196, HPA057511 Supported Approved Vesicles Expressed in all gallbladder: 44.5 STX1A HPC-1, p35-1, STX1 ENSG00000106089 Syntaxin 1A (brain) 7 73699206-73719672 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008372, HPA069176 Supported Tissue enriched 15 cerebral cortex: 167.1 gallbladder: 10.8 STX4 p35-2, STX4A ENSG00000103496 Syntaxin 4 16 31032889-31042975 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001330 Approved Validated Plasma membrane Expressed in all parathyroid gland: 63.4 SUN1 FLJ12407, KIAA0810, UNC84A ENSG00000164828 Sad1 and UNC84 domain containing 1 7 816615-896435 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008346, HPA008461 Supported Validated Nuclear membrane Expressed in all endometrium: 120.0 SYT1 P65, SVP65, SYT ENSG00000067715 Synaptotagmin I 12 78863993-79452008 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008394, HPA064788 Supported Tissue enriched 13 cerebral cortex: 477.9 smooth muscle: 36.4 TMBIM4 CGI-119, GAAP, LFG4, S1R, ZPRO ENSG00000155957 Transmembrane BAX inhibitor motif containing 4 12 66135846-66170072 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA077642 Supported Golgi apparatus Expressed in all thyroid gland: 164.8 TMBIM6 BAXI1, BI-1, TEGT ENSG00000139644 Transmembrane BAX inhibitor motif containing 6 12 49707725-49764934 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017378 Approved Expressed in all kidney: 1179.3 TMC6 EVER1, EVIN1, LAK-4P ENSG00000141524 Transmembrane channel-like 6 17 78110458-78132407 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051430 Uncertain Expressed in all spleen: 84.5 TMC8 EVER2, EVIN2 ENSG00000167895 Transmembrane channel-like 8 17 78130770-78142968 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047387, HPA054429 Uncertain Uncertain Golgi apparatus Tissue enhanced 0 lymph node: 120.4;spleen: 107.5 appendix: 75.5 TMEM109 MGC5508 ENSG00000110108 Transmembrane protein 109 11 60913874-60923443 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011785 Approved Approved Nuclear membrane
Cytosol Expressed in all endometrium: 94.2 TMEM175 MGC4618 ENSG00000127419 Transmembrane protein 175 4 932387-958656 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057160 Approved Approved Nucleus
Nuclear membrane Expressed in all cerebral cortex: 20.8 TMEM63B C6orf110, dJ421H19.2, DKFZp434P0531 ENSG00000137216 Transmembrane protein 63B 6 44126914-44155519 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029249, HPA029250, HPA029251 Uncertain Validated Plasma membrane
Actin filaments Expressed in all lung: 59.2 TMEM63C C14orf171, CSC1, DKFZp434P0111, hsCSC1 ENSG00000165548 Transmembrane protein 63C 14 77116568-77259495 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030657 Uncertain Approved Centrosome Tissue enhanced 0 adrenal gland: 12.9;cerebral cortex: 18.6;testis: 13.8 epididymis: 5.5 TNFAIP2 B94, EXOC3L3 ENSG00000185215 Tumor necrosis factor, alpha-induced protein 2 14 103123442-103137439 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB004598, HPA030624 Supported Approved Nucleus
Nuclear membrane
Golgi apparatus
Cytosol Expressed in all urinary bladder: 211.4 TNKS PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1 ENSG00000173273 Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 8 9555914-9782346 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA025690 Approved Approved Nucleoplasm
Nuclear membrane Expressed in all testis: 52.7 TNPO1 IPO2, KPNB2, MIP, MIP1, TRN ENSG00000083312 Transportin 1 5 72816312-72916733 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016325 Approved Supported Nucleoplasm
Cytosol
Cytoplasmic bodies Expressed in all parathyroid gland: 108.4 TNPO2 FLJ12155, IPO3, KPNB2B, TRN2 ENSG00000105576 Transportin 2 19 12699194-12724011 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB046446, HPA071498 Approved Approved Nucleus
Nucleoli Expressed in all cerebral cortex: 91.2 TOMM40 C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40 ENSG00000130204 Translocase of outer mitochondrial membrane 40 homolog (yeast) 19 44890569-44903689 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036231, HPA036232 Supported Validated Mitochondria
Cytosol Expressed in all appendix: 35.2 TP53 LFS1, p53 ENSG00000141510 Tumor protein p53 17 7661779-7687550 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002973, CAB039238, CAB039239, HPA051244, CAB072876 Supported Validated Nucleoplasm Expressed in all fallopian tube: 50.3 TPCN1 FLJ20612, KIAA1169, TPC1 ENSG00000186815 Two pore segment channel 1 12 113221050-113298585 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039757 Approved Expressed in all thyroid gland: 53.3 TPCN2 TPC2 ENSG00000162341 Two pore segment channel 2 11 69048897-69090604 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016561, HPA027080 Supported Approved Nucleoli Mixed endometrium: 11.7 TPR ENSG00000047410 Translocated promoter region, nuclear basket protein 1 186311652-186375693 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019661, HPA019663, HPA024336 Supported Validated Nuclear membrane Expressed in all testis: 78.8 TRIM72 MG53 ENSG00000177238 Tripartite motif containing 72, E3 ubiquitin protein ligase 16 31214021-31231537 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023122, HPA054909 Supported Approved Nucleus
Nucleoli Tissue enriched 21 skeletal muscle: 52.5 prostate: 2.4 TRPA1 ANKTM1 ENSG00000104321 Transient receptor potential cation channel, subfamily A, member 1 8 72019917-72075617 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026630 Uncertain Tissue enhanced 0 urinary bladder: 30.5 gallbladder: 11.4 TRPC1 HTRP-1 ENSG00000144935 Transient receptor potential cation channel, subfamily C, member 1 3 142724074-142807888 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009387, HPA021130 Supported Approved Vesicles Mixed endometrium: 18.5 TRPC3 ENSG00000138741 Transient receptor potential cation channel, subfamily C, member 3 4 121879027-121951754 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA037969 Uncertain Tissue enhanced 0 smooth muscle: 4.1 cerebral cortex: 2.1 TRPC5 PPP1R159 ENSG00000072315 Transient receptor potential cation channel, subfamily C, member 5 X 111774315-112082776 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.9 liver: 0.4 TRPC6 FSGS2, TRP6 ENSG00000137672 Transient receptor potential cation channel, subfamily C, member 6 11 101451564-101872562 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045098, HPA062164 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 placenta: 29.8 lung: 20.0 TRPM2 EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7 ENSG00000142185 Transient receptor potential cation channel, subfamily M, member 2 21 44350163-44443081 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030976, HPA035260 Approved Approved Nuclear membrane Mixed bone marrow: 18.9 TRPM3 GON-2, KIAA1616, LTRPC3 ENSG00000083067 Transient receptor potential cation channel, subfamily M, member 3 9 70529063-71446904 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 17.5 testis: 6.3 TRPM4 FLJ20041 ENSG00000130529 Transient receptor potential cation channel, subfamily M, member 4 19 49157741-49211836 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041169 Supported Supported Nucleoplasm
Plasma membrane Mixed colon: 27.5 TRPM5 LTRPC5, MTR1 ENSG00000070985 Transient receptor potential cation channel, subfamily M, member 5 11 2404515-2423045 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042115, HPA043315 Approved Group enriched 5 colon: 1.0;duodenum: 3.0;epididymis: 2.2;seminal vesicle: 2.5;small intestine: 2.9 thyroid gland: 0.4 TRPM6 CHAK2, FLJ22628, HOMG, HSH ENSG00000119121 Transient receptor potential cation channel, subfamily M, member 6 9 74722495-74888094 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 colon: 13.3;rectum: 18.5 small intestine: 8.9 TRPM7 CHAK1, LTRPC7, TRP-PLIK ENSG00000092439 Transient receptor potential cation channel, subfamily M, member 7 15 50552473-50686815 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035523, HPA052173 Uncertain Approved Nucleoplasm Tissue enriched 7 parathyroid gland: 212.8 thyroid gland: 29.0 TRPV1 VR1 ENSG00000196689 Transient receptor potential cation channel, subfamily V, member 1 17 3565444-3609411 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Mixed duodenum: 8.0 TRPV2 VRL, VRL-1, VRL1 ENSG00000187688 Transient receptor potential cation channel, subfamily V, member 2 17 16415542-16437003 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044993 Uncertain Supported Plasma membrane Mixed lung: 44.1 TRPV5 CaT2, ECAC1 ENSG00000127412 Transient receptor potential cation channel, subfamily V, member 5 7 142908101-142933808 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA063175 Approved Not detected kidney: 0.5 TRPV6 CaT1, ECAC2 ENSG00000165125 Transient receptor potential cation channel, subfamily V, member 6 7 142871203-142885762 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA062864 Approved Tissue enhanced 0 prostate: 38.7;salivary gland: 29.3 placenta: 17.4 TTYH1 ENSG00000167614 Tweety family member 1 19 54415219-54436900 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023617, HPA050655 Approved Tissue enriched 27 cerebral cortex: 57.9 testis: 2.1 TTYH2 C17orf29 ENSG00000141540 Tweety family member 2 17 74213514-74262020 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 129.6 testis: 21.8 TUSC3 MGC13453, MRT7, N33, OST3A ENSG00000104723 Tumor suppressor candidate 3 8 15417215-15766649 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049851, HPA049974 Approved Mixed epididymis: 140.7 VAMP1 SYB1, VAMP-1 ENSG00000139190 Vesicle-associated membrane protein 1 (synaptobrevin 1) 12 6462237-6470987 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002779, CAB016119 Approved Mixed cerebral cortex: 43.6 VAMP2 SYB2, VAMP-2 ENSG00000220205 Vesicle-associated membrane protein 2 (synaptobrevin 2) 17 8159149-8163546 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB078785 Supported Expressed in all cerebral cortex: 485.0 VAMP8 EDB ENSG00000118640 Vesicle-associated membrane protein 8 2 85561562-85582031 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006882, CAB037132, CAB037147 Supported Expressed in all lung: 328.4 VDAC2 ENSG00000165637 Voltage-dependent anion channel 2 10 75210154-75231448 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043475 Supported Validated Mitochondria Expressed in all esophagus: 266.4 XPO1 CRM1, emb ENSG00000082898 Exportin 1 2 61477849-61538626 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010184, HPA042933 Supported Validated Nucleoplasm
Nuclear membrane
Vesicles
Cytosol Expressed in all testis: 138.5 XPO4 FLJ13046, KIAA1721 ENSG00000132953 Exportin 4 13 20777329-20903048 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053768 Supported Nucleoplasm
Cytosol Mixed skeletal muscle: 15.7 XPO5 KIAA1291 ENSG00000124571 Exportin 5 6 43522330-43576075 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012357, HPA018402, HPA023959, HPA029909, HPA029910 Supported Validated Nucleoplasm Expressed in all testis: 43.4 XPO7 KIAA0745, RANBP16 ENSG00000130227 Exportin 7 8 21919671-22006585 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043727, HPA048153 Uncertain Approved Nucleus Expressed in all parathyroid gland: 77.3 XPOT XPO3 ENSG00000184575 Exportin, tRNA 12 64404350-64451127 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048067, HPA057602 Validated Nucleoplasm
Cytosol Expressed in all thyroid gland: 82.9